Literature DB >> 2038067

Preserving effect of fructose-1,6-bisphosphate on high-energy phosphate compounds during anoxia and reperfusion in isolated langendorff-perfused rat hearts.

G Lazzarino1, M E Nuutinen, B Tavazzi, L Cerroni, D Di Pierro, B Giardina.   

Abstract

Isolated Langendorff-perfused rat hearts after 10 min pre-perfusion, were subjected to a substrate-free anoxic perfusion (20 min) followed by 20 min reperfusion with a glucose-containing oxygen-balanced medium. A similar experimental protocol was repeated in the presence either of 5 mM fructose or of 5 mM fructose-1,6-bisphosphate throughout the different perfusion conditions. High-energy phosphate compounds (adenosine triphosphate, creatine phosphate), adenine nucleotides, nicotinic coenzymes, lactate, pyruvate and glycogen content in the tissue were determined at the end of each perfusion period, while coronary flow, heart rate and lactate and pyruvate output were monitored throughout the whole duration of the experiments. On the whole, the results indicate that exogenous fructose-1,6-bisphosphate preserves high-energy metabolites during anoxia and restores myocardial metabolism and contractility during reperfusion, that a prolonged period of substrate-free anoxic perfusion renders the heart unable to normalize its metabolism during re-oxygenation and that fructose is not utilized by the heart for its energy demand. A possible hypothesis concerning the mechanism of action of fructose-1,6-bisphosphate is presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2038067     DOI: 10.1016/0022-2828(91)90035-k

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  12 in total

1.  Use of an Escherichia coli recombinant producing thermostable polyphosphate kinase as an ATP regenerator to produce fructose 1,6-diphosphate.

Authors:  Seishi Iwamoto; Kei Motomura; Yasuharu Shinoda; Masaaki Urata; Junichi Kato; Noboru Takiguchi; Hisao Ohtake; Ryuichi Hirota; Akio Kuroda
Journal:  Appl Environ Microbiol       Date:  2007-07-06       Impact factor: 4.792

2.  The role of fructose-1,6-diphosphate in cell migration and proliferation in an in vitro xenograft blood vessel model of vascular wound healing.

Authors:  H H Cohly; J W Stephens; M F Angel; J C Johnson; A K Markov
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-10       Impact factor: 2.416

3.  Transport and metabolism of exogenous fumarate and 3-phosphoglycerate in vascular smooth muscle.

Authors:  D R Finder; C D Hardin
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

4.  Fructose-1,6-bisphosphate as a metabolic substrate in hog ileum smooth muscle during hypoxia.

Authors:  T M Juergens; C D Hardin
Journal:  Mol Cell Biochem       Date:  1996-01-12       Impact factor: 3.396

5.  Membrane permeability of fructose-1,6-diphosphate in lipid vesicles and endothelial cells.

Authors:  W D Ehringer; W Niu; B Chiang; O L Wang; L Gordon; S Chien
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

6.  The uptake and metabolism of fructose-1,6-diphosphate in rat cardiomyocytes.

Authors:  W D Ehringer; B Chiang; S Chien
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

7.  Destabilizing effects of fructose-1,6-bisphosphate on membrane bilayers.

Authors:  William D Ehringer; Susan Su; Benjamin Chiangb; William Stillwell; Sufan Chien
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

8.  Is oxygen supply sufficient to induce normoxic conditions in isolated rat heart?

Authors:  C Poizat; C Keriel; P Cuchet
Journal:  Basic Res Cardiol       Date:  1994 Nov-Dec       Impact factor: 17.165

9.  Exogenous fructose-1,6-bisphosphate is a metabolizable substrate for the isolated normoxic rat heart.

Authors:  B Tavazzi; J W Starnes; G Lazzarino; D Di Pierro; E M Nuutinen; B Giardina
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

Review 10.  Current state of hypothermic machine perfusion preservation of organs: The clinical perspective.

Authors:  Michael J Taylor; Simona C Baicu
Journal:  Cryobiology       Date:  2009-10-24       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.